Kleo Pharmaceuticals is developing synthetic immunotherapies that redirect the human immune system to fight diseases. We are headquartered in New Haven, CT.
Great article by our scientific founder David Spiegel on potential strategies to battle COVID-19. # #vaccines#immunization#covidー19
https://t.co/o4XNcKJof7?